Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271072 · ClinicalTrials.gov registry record
CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 81
- Enrollment target
NCT04271072: Completed study, sponsored by Duke University.
NCT04271072 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 81 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04271072 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
Study Summary
The aim is to investigate if inflammatory biomarkers in the blood and cerebrospinal fluid (CSF) are associated with the development of perinatal depression and/or persistent pain after cesarean delivery. This study will obtain CSF and blood samples in 70 parturients. All parturients will be assessed for perinatal depression and persistent pain, and the presence/absence of these outcomes will be correlated to changes in the inflammatory biomarkers within the samples collected. If present, consistent changes in biomarkers correlating with perinatal depression or persistent pain may be utilised as a predictive tool and facilitate early treatment for these conditions.
Primary Outcome
Edinburgh postnatal depression scale \>=10 (minimum 0, maximum 30, increasing score indicates higher likelihood of depression)
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2020-02-01 |
| Est. Completion | 2022-02-28 |
What the finished NCT04271072 record still lists
NCT04271072 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 81 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04271072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04271072 about?
NCT04271072 is a clinical study titled "CSF/Serum Biomarkers in Predicting PND/Persistent Pain After Cesarean". The aim is to investigate if inflammatory biomarkers in the blood and cerebrospinal fluid (CSF) are associated with the development of perinatal depression and/or persistent pain after cesarean delivery. This study will obtain CSF and blood samples in 70 parturients. All parturients will be assesse...
What is the current status of trial NCT04271072?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2020-02-01. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04271072?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04271072?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI